Ally Financial Inc.

▲ Bull Case

• ◆NIM expansion is mechanical and likely under-priced by the Street — ALLY's auto-loan book has a ~24-month half-life; new originations at 8–9% are replacing 5–6% loans. With stable deposit costs (beta ~55% on the way down), NIM should exit 2026 at the high end of guidance (3.65–3.70%) and sustain 3.65–3.75% through 2027. Street guides mid-3.50s; the variance suggests $0.25–0.35 EPS upside vs. consensus. At 12x forward P/E, that's $3–4 of price target upside.
• ◆Capital-return acceleration is both likely and underpriced — Once CET1 crosses 8.5% (fully-phased), ALLY will have $6–8B of excess capital above regulatory floors. With no card-growth to fund, management can return $1.5–2.0B annually via buybacks. At $42 stock, this generates 3–4% annual per-share EPS accretion. Markets are modeling $0.5–1.0B; the upside scenario is 2x higher.
• ◆The franchise is simpler and more resilient post-2025 — Credit-card divestiture removed the highest-loss segment and eliminated a sub-scale distraction. ALLY is now a pure-play auto-finance + digital-deposits story with durable competitive advantages: (a) largest non-captive auto platform (22K dealer relationships built over decades), (b) structural cost advantage in deposits (all-digital, no branches), (c) prime+ credit skew (80%) limits recession tail-risk. Through-cycle ROTCE of 12–13% justifies 1.2–1.3x P/TBV ($60–65 TBVPS $50). Current 1.05x multiple leaves room for re-rating.

▼ Bear Case

• ◆Auto credit is cyclic and subprime contagion risk is real — 2024 NCO peak (2.0%) has cooled to 1.60%, but this is partial-cycle improvement, not trough. If unemployment rises to 5%+ or used-car prices roll over (Manheim index down 10%+), NCO can reaccelerate to 2.5–3.0% and wipe out $0.50–1.00 of EPS. ALLY's origination volume is also sensitive to dealer-finance demand; a recession cuts origination to $8B quarterly (vs. $11.5B today). The bear case EPS: $2.50–3.00 FY2026E vs. base $4.50.
• ◆NIM could stall or compress if Fed cuts faster than expected — Street guides 3.60–3.70% NIM by year-end, but if the Fed cuts 100+ bps (vs. 50–75 bps consensus), deposit beta could exceed 60% and compress NIM back to 3.40–3.50%. This would cost $200–300M annual net interest income and ~$0.30 EPS. The AOCI portfolio would also reaccumulate losses, pressuring capital and delaying buyback approval.
• ◆Buyback restart could be delayed and dilution from equity issuance looms — If AOCI swings negative again (10Y rates spike), ALLY's fully-phased CET1 could drop to 7.5–8.0%, leaving no room for buybacks. Management may be forced to raise equity via capital offering, diluting shares 5–10%. This would offset the mechanical EPS tailwind from NIM and credit normalization.

“The central disagreement is on capital-return timing and magnitude. Bull consensus (Evercore ISI, TipRanks): NIM exits FY2026 at high end of guidance; buyback restarts Q3 2026 at $1.5B+ run-rate. FY2026E EPS $4.50–5.00; FY2027E $5.50–6.00. Price target $51–70 (14–15x forward). Bernstein, Wells Fargo aligned. Bear view (Morgan Stanley, JPMorgan): CCAR delays buyback approval to 2027 mid-year; NIM stalls at 3.55%; credit normalizes slower. FY2026E EPS $4.00–4.25; FY2027E $4.80–5.20. Price target $40–48 (9–10x forward). Street consensus has shrunk to just 2 Sell/Hold calls vs. 14 Buy. The core tension: Can ALLY execute 50 bps of NIM expansion while sustaining modest credit losses, and will CCAR bless aggressive capital return—or will macro surprise force conservatism?”

• ◆Q2 2026 earnings (Jul) — NIM ≥3.55% ex-OID and NCO ≤1.65% would confirm base-case inflection
• ◆CCAR 2026 (Jun) — Capital-return approval ≥$1.5B for H2 2026 signals management confidence
• ◆Q3 2026 earnings (Oct) — Buyback execution $300M+ would confirm restart and trigger re-rating
• ◆2027 guidance (Jan) — EPS $5.50+ and $1.5B buyback run-rate would raise bull-case target
• ◆Q2 2027 earnings (Jul) — Through-cycle ROTCE proven ≥13% enters re-rating and harvest window

• ◆Recession + auto credit reacceleration (25–30% probability) — NCO spike to 2.5–3.0% would cost $1.00–2.00 EPS and 40–50% downside
• ◆Fed cuts 100+ bps faster than consensus (15–20% probability) — Deposit-beta compression could reduce EPS $0.30–0.50
• ◆AOCI swing negative again (20–25% probability) — 10Y rate spike would defer capital actions and cost $0.80–1.20 EPS
• ◆Deposit beta exceeds 60% on rate cuts (30–40% probability) — Would compress NIM $0.20–0.40 per 100 bps cut
• ◆Auto-origination volume collapse (10–15% probability) — Recession or demand shock could reduce EPS $0.40–0.80